Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Revol

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
JAMA Internal Medicine|April 27, 2021
Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance DatabaseLucie Renoud, Charles Khouri, Bruno Revol, et al.
Frontiers in Pharmacology|June 14, 2021
Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection PerformancesCharles Khouri, Thuy Nguyen, Bruno Revol, et al.
Therapie|July 29, 2019
[Acute coronary syndrome associated with dronabinol]Bruno Revol, Caroline Chittaro, Pierre Frey, et al.
Journal of Clinical Epidemiology|January 28, 2021
Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most casesCharles Khouri, Camille Petit, Michel Tod, et al.
Expert Review of Respiratory Medicine|April 25, 2019
Diagnosis and management of central sleep apnea syndromeSébastien Baillieul, Bruno Revol, Ingrid Jullian-Desayes, et al.
Annals of Clinical Biochemistry|March 21, 2025
Underreporting of synthetic cathinone poisoning with clinical immunoassays: An experimental and observational studyThéo Willeman, Mathis Laudet, Bruno Revol, et al.
British Journal of Haematology|September 12, 2025
A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemiaGuillaume Brenac, Anne Dautriche, Romane Freppel, et al.
International Journal of Legal Medicine|April 13, 2026
Emergence of 2-MMC in the French Alps: description of 13 clinical and forensic toxicology casesCoralie Boudin, Bruno Revol, Hélène Eysseric-Guérin, et al.
Therapie|August 21, 2025
Drugs associated with behavioral addictions: Real world analysis using the WHO pharmacovigilance databaseLouis Asselin, Edouard-Jules Laforgue, Mélanie Duval, et al.
Journal of the American College of Cardiology|May 19, 2018
Ticagrelor and Central Sleep ApneaBruno Revol, Ingrid Jullian-Desayes, Renaud Tamisier, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
JAMA Internal Medicine|April 27, 2021
Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance DatabaseLucie Renoud, Charles Khouri, Bruno Revol, et al.
Frontiers in Pharmacology|June 14, 2021
Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection PerformancesCharles Khouri, Thuy Nguyen, Bruno Revol, et al.
Therapie|July 29, 2019
[Acute coronary syndrome associated with dronabinol]Bruno Revol, Caroline Chittaro, Pierre Frey, et al.
Journal of Clinical Epidemiology|January 28, 2021
Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most casesCharles Khouri, Camille Petit, Michel Tod, et al.
Expert Review of Respiratory Medicine|April 25, 2019
Diagnosis and management of central sleep apnea syndromeSébastien Baillieul, Bruno Revol, Ingrid Jullian-Desayes, et al.
Annals of Clinical Biochemistry|March 21, 2025
Underreporting of synthetic cathinone poisoning with clinical immunoassays: An experimental and observational studyThéo Willeman, Mathis Laudet, Bruno Revol, et al.
British Journal of Haematology|September 12, 2025
A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemiaGuillaume Brenac, Anne Dautriche, Romane Freppel, et al.
International Journal of Legal Medicine|April 13, 2026
Emergence of 2-MMC in the French Alps: description of 13 clinical and forensic toxicology casesCoralie Boudin, Bruno Revol, Hélène Eysseric-Guérin, et al.
Therapie|August 21, 2025
Drugs associated with behavioral addictions: Real world analysis using the WHO pharmacovigilance databaseLouis Asselin, Edouard-Jules Laforgue, Mélanie Duval, et al.
Journal of the American College of Cardiology|May 19, 2018
Ticagrelor and Central Sleep ApneaBruno Revol, Ingrid Jullian-Desayes, Renaud Tamisier, et al.
Pageof 6